All Industry articles – Page 12
-
BusinessChemicals industry roundup 2020
Pandemic provides impetus to re-tune supply chains for resilience and sustainability
-
Business
Pharmaceuticals roundup 2020
Alongside the race for Covid-19 treatments and vaccines, the industry has maintained momentum
-
Business
Pfizer–BioNTech vaccine gains emergency approvals in US, Canada and beyond
UK begins vaccinating vulnerable populations after early authorisation
-
Business
Fatal explosion at US chemical plant
Blast at Optima facility killed one and injured three others
-
Opinion
Stirring in my sleep
Cut off from the lab after 40 years, Derek Lowe returns to the bench in his dreams
-
Sponsored
Immunity trend puts vitamin fortification centre stage
Manufacturers look to meet consumer demand for immune-strengthening products in the wake of Covid-19
-
Business
4 dead in UK sewage treatment works explosion
One person injured as biosolids silo explodes at Avonmouth
-
Business
UK grants Pfizer–BioNTech Covid-19 vaccine emergency approval
Regulators around the world working towards accelerated decisions on vaccine data
-
Business
Brexit may put some chemicals out of GB’s Reach
Industry fears divergence of UK and EU regulations could spell disaster for trade
-
-
Business
Oxford–AstraZeneca vaccine joins others with promising interim data
Cheap and fridge-stable candidate at least 60% and up to 90% effective at preventing disease
-
Business
Taking plastic out of performance paper coatings
SGMA’s silicate sol-gel is a sustainable alternative for packaging such as coffee cups
-
Business
Regulatory panel unconvinced by Alzheimer’s antibody evidence
US FDA advisors vote against approving Biogen’s aducanumab on the basis of incomplete data analysis
-
Business
Moderna and Pfizer’s Covid-19 vaccines add more encouraging data
Pfizer–BioNTech reach safety threshold for emergency authorisation, while Moderna’s data peek suggests 95% efficacy
-
Opinion
The ins and outs of vaccine trials
Derek Lowe lays out how the trials work, and why they get paused and restarted
-
Opinion
A promising peep at Covid-19 vaccine efficacy
Pfizer–BioNTech’s will need to be one of many if we are to overcome the pandemic
-
Business
Early indications suggest Pfizer–BioNTech’s Covid-19 vaccine is effective
Company claims 90% efficacy at preventing disease, but experts call for data rather than press releases
-
Business
Innovation is a fragile transition state
Brexit and Covid-19 will likely stifle interactions, but could also stimulate new ones
-
News
US imposes sanctions on Russian institution linked to refinery cyber attack
Russia’s Chemistry and Mechanics research institute is accused of connections to Triton malware
-
Business
Stepping towards diversity in industry
Companies are re-affirming their commitment to inclusivity, even as the US government obstructs education efforts
